- Report
- December 2024
- 200 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- October 2024
- 200 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- May 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- May 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- May 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- October 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP
- Report
- August 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP
- Report
- July 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP
- Report
- May 2023
- 450 Pages
Global
From €4379EUR$5,000USD£3,801GBP
- Report
- April 2023
- 399 Pages
Global
From €8320EUR$9,500USD£7,222GBP
- Report
- April 2023
- 105 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2024
- 120 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Report
- December 2023
- 140 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- July 2024
- 171 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- September 2023
- 115 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- May 2023
- 120 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- July 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- June 2024
- 140 Pages
Europe
From €3389EUR$3,869USD£2,941GBP
- Report
- April 2023
- 147 Pages
Global
From €4334EUR$4,949USD£3,762GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more